A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
about
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancerHepatotoxicity Secondary to ChemotherapyCancer concepts and principles: primer for the interventional oncologist-part IIPrediction of cancer drugs by chemical-chemical interactionsA phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma.Hepatic artery chemotherapy in the management of colorectal metastases.Review article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.Chemotherapy and other systemic therapies for hepatocellular carcinoma and liver metastases.Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.Recent and ongoing clinical trials for treating colorectal cancer.Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administrationHepatic arterial chemotherapy for metastatic colorectal carcinoma.Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Transcatheter intraarterial therapies: rationale and overviewHepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastasesHemorrhage associated with hepatic artery pseudoaneurysms after regional chemotherapy with floxuridine: case report.Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.Intravital microscopic research of microembolization with degradable starch microspheres.Minimally invasive evaluation and treatment of colorectal liver metastases.Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.Advances in understanding of colorectal liver metastasis and implications for the clinic.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.Intra-hepatic arterial drug delivery.Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy.Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.Liver-directed therapy in metastatic colorectal cancer.Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic diseaseBiliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk FactorsPostoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)
P2860
Q24240109-41D2A522-426F-44B3-BE34-0C7556CB8FC5Q26861560-C9E60C93-DA2F-4642-9D7F-9C2C75157987Q27010961-BF5C32DC-5BA6-4FB1-9C58-F2B0AEF39EC7Q28539449-04D774E3-9AFE-4190-87F0-FA1EDD23E50AQ33390290-BC7DCC44-B7A8-4B9C-B29C-B75A05073B77Q33502056-C6D8C08F-938D-4C10-AE63-7F7F08CE4D7AQ34110958-29F2A3AE-7A5B-47D1-A921-EC2686B59C42Q34116771-B9908E85-C731-4DA4-818B-57D8628DE84DQ34374142-A732909B-903C-49B5-931D-55CF28FED23FQ34563336-6CA65D75-6526-4F22-A536-5B2C4B4E1FD6Q34565424-07196B59-DE6E-4509-A2D1-38C9CDF68B4EQ34660903-05D5D6A3-1228-4AB5-8BDB-D2EDE1DF4877Q35056479-18224CDB-770B-42DF-A35E-683788EC0879Q35830597-590EB215-8374-4AB6-BB50-0BE9CA691B92Q35977692-A4983DC8-03EF-44F5-A54D-9FCC42A3D4ADQ36067527-445361C2-0961-413E-B9C9-403A89410881Q36097254-F15673FA-5F17-47F0-B171-0D66591C6BC4Q36104314-A62B4104-E983-41E6-B106-6C11F6305312Q36409952-9711E88A-7AEC-4D5A-9564-1B1CCF215EE7Q36431417-8D8709CB-6710-44EC-ACF7-4400279F5EE0Q36782377-EB3CC512-5427-4A0F-BA86-52DD80DCAD0EQ36986088-1F9A30C0-D7E1-4CCD-A88E-71559AACE95CQ37254998-9656D34E-ECAB-4904-99C2-18F1F1A0F1A5Q37353624-0FF4E615-32A7-42CD-A8A6-2E237944EB6DQ37982074-79515C44-6155-4791-B50C-F4ED582FF2E2Q38037067-22F05FDF-A15B-45E8-A0B0-CA002397C49AQ38230654-048630CD-DFB4-4CE9-B38E-ACF9BBD08D04Q38664762-36BDC0A5-5A04-4F4E-B56C-D34B21466CD3Q39710451-F351F712-081D-4AA5-8C9A-19B01DF4C7E9Q41160084-D40F6AFE-805E-438C-B1FC-347ABCDDADA8Q41809290-F7936FA3-7EBA-43A0-BC4F-7BB3EDF51A80Q41946954-DC476195-8B72-4814-828E-BA3F307760B0Q43937971-7D6616C0-5994-4189-9964-20350C12D4F4Q51804221-D3AED767-3E79-4F8F-858C-46F2C4950AABQ51842624-634C79B1-3B0B-4267-A199-6B3931108392Q57823332-713C249A-FA3F-4FF9-A3C2-2658E6CC0B29Q57823392-B13A7924-D763-4167-B2C6-0AFC53E190A5Q58799367-64FF20EC-8C6A-4AEC-957B-643F577305B4
P2860
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A randomized trial of continuo ...... lifornia Oncology Group trial.
@ast
A randomized trial of continuo ...... lifornia Oncology Group trial.
@en
A randomized trial of continuo ...... lifornia Oncology Group trial.
@nl
type
label
A randomized trial of continuo ...... lifornia Oncology Group trial.
@ast
A randomized trial of continuo ...... lifornia Oncology Group trial.
@en
A randomized trial of continuo ...... lifornia Oncology Group trial.
@nl
prefLabel
A randomized trial of continuo ...... lifornia Oncology Group trial.
@ast
A randomized trial of continuo ...... lifornia Oncology Group trial.
@en
A randomized trial of continuo ...... lifornia Oncology Group trial.
@nl
P2093
P921
P1476
A randomized trial of continuo ...... lifornia Oncology Group trial.
@en
P2093
J F Hannigan
M A Friedman
R J Ignoffo
P304
P356
10.1200/JCO.1989.7.11.1646
P407
P577
1989-11-01T00:00:00Z